Chugai News Releases are issued to provide stakeholders with the most up-to-date information related to our company. In some instances, information on products or drug candidates under development may be included, but this is intended for members of the media, shareholders, and investors. The information is not intended for promotional or advertising purposes, or as medical advice, etc.
Jan 22, 2021
Chugai and Taisho Terminate the Co-Marketing Agreement of Edirol®, a Treatment for Osteoporosis
Jan 18, 2021
Chugai Supports the Japan Climate Initiative’s Calling to Raise 2030 Renewable Energy Target
Jan 12, 2021
Chugai Conducts Digital Transformation in Manufacturing with IBM Japan to Realize a Digital Plant